Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions
- PMID: 26587015
- PMCID: PMC4637490
- DOI: 10.1155/2015/271983
Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions
Abstract
Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear family of ligand activated transcriptional factors and comprise three different isoforms, PPAR-α, PPAR-β/δ, and PPAR-γ. The main role of PPARs is to regulate the expression of genes involved in lipid and glucose metabolism. Several studies have demonstrated that PPAR agonists improve dyslipidemia and glucose control in animals, supporting their potential as a promising therapeutic option to treat diabetes and dyslipidemia. However, substantial differences exist in the therapeutic or adverse effects of specific drug candidates, and clinical studies have yielded inconsistent data on their cardioprotective effects. This review summarizes the current knowledge regarding the molecular function of PPARs and the mechanisms of the PPAR regulation by posttranslational modification in the heart. We also describe the results and lessons learned from important clinical trials on PPAR agonists and discuss the potential future directions for this class of drugs.
Figures
Similar articles
-
Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials.Biol Reprod. 2010 Aug 1;83(2):168-76. doi: 10.1095/biolreprod.110.083550. Epub 2010 Apr 28. Biol Reprod. 2010. PMID: 20427759 Review.
-
Evolution of peroxisome proliferator-activated receptor agonists.Ann Pharmacother. 2007 Jun;41(6):973-83. doi: 10.1345/aph.1K013. Epub 2007 May 22. Ann Pharmacother. 2007. PMID: 17519293 Review.
-
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.Cardiovasc Diabetol. 2005 Sep 16;4:14. doi: 10.1186/1475-2840-4-14. Cardiovasc Diabetol. 2005. PMID: 16168052 Free PMC article. Review.
-
An overview on biological mechanisms of PPARs.Pharmacol Res. 2005 Feb;51(2):85-94. doi: 10.1016/j.phrs.2004.07.012. Pharmacol Res. 2005. PMID: 15629253 Review.
-
Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.Biochimie. 1997 Feb-Mar;79(2-3):81-94. doi: 10.1016/s0300-9084(97)81496-4. Biochimie. 1997. PMID: 9209701 Review.
Cited by
-
Hemodynamic Melody of Postnatal Cardiac and Pulmonary Development in Children with Congenital Heart Diseases.Biology (Basel). 2024 Mar 31;13(4):234. doi: 10.3390/biology13040234. Biology (Basel). 2024. PMID: 38666846 Free PMC article. Review.
-
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
-
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes.Pharmaceutics. 2023 Jan 6;15(1):202. doi: 10.3390/pharmaceutics15010202. Pharmaceutics. 2023. PMID: 36678831 Free PMC article.
-
Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor.Front Med (Lausanne). 2022 Nov 25;9:1060244. doi: 10.3389/fmed.2022.1060244. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36507526 Free PMC article. Review.
-
The Potential Role of PPARs in the Fetal Origins of Adult Disease.Cells. 2022 Nov 2;11(21):3474. doi: 10.3390/cells11213474. Cells. 2022. PMID: 36359869 Free PMC article. Review.
References
-
- Desvergne B., Wahli W. Peroxisome proliferator activated receptors: nuclear control of metabolism. Endocrine Reviews. 1999;20(5):649–688. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous